2026-04-04_00000378
|
ligand
|
9ZZW
Structure of human MARK3 in complex with inhibitor;
X-ray diffraction 2.76Å
Protein #1
325 residues (93% resolved)
Raw Sequence ...
GAMDPDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKYDEITATYLLLGRK
Canonical Sequence ...
GAMDPDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESLSKMKYDEITATYLLLGRK
Non polymer #2
A1C86
InChI=1S/C24H28ClN7O2/c1-3-31-10-12-32(13-11-31)16-8-9-20(21(14-16)34-2)29-24-27-15-18(25)23(30-24)28-19-7-5-4-6-17(19)22(26)33/h4-9,14-15H,3,10-13H2,1-2H3,(H2,26,33)(H2,27,28,29,30)
InChI=1S/C24H28ClN7O2/c1-3-31-10-12-32(13-11-31)16-8-9-20(21(14-16)34-2)29-24-27-15-18(25)23(30-24)28-19-7-5-4-6-17(19)22(26)33/h4-9,14-15H,3,10-13H2,1-2H3,(H2,26,33)(H2,27,28,29,30)
SMILES: CCN1CCN(CC1)c2ccc(c(c2)OC)Nc3ncc(c(n3)Nc4ccccc4C(=O)N)Cl
CCN1CCN(CC1)c2ccc(c(c2)OC)Nc3ncc(c(n3)Nc4ccccc4C(=O)N)Cl
Biounit #1
monomer
Download coordinates
Biounit #2
monomer
Download coordinates
Tube
Model
Reference
100%